PTK2 and neoplasm: A subsequent study evidenced that LOX expression and activity are sharply higher in tumor endothelial cells than in normal cells and that LOX knockdown limits tumor endothelial cell motility and tubulogenesis through the inhibition of FAK signaling [92].